Secretome Therapeutics Announces $30 Million Series A Financing
From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy